| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lenka Hruba, Brett C Ginsburg, Lance R McMaho. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys. The Journal of pharmacology and experimental therapeutics. vol 342. issue 3. 2013-03-07. PMID:22718500. |
synthetic cannabinoids (cbs) [naphthalen-1-yl-(1-pentylindol-3-yl) methanone (jwh-018) and naphthalen-1-yl-(1-butylindol-3-yl) methanone (jwh-073)] are marketed, sold, and used as alternatives to cannabis. |
2013-03-07 |
2023-08-12 |
monkey |
| F M Leweke, D Piomelli, F Pahlisch, D Muhl, C W Gerth, C Hoyer, J Klosterkötter, M Hellmich, D Koeth. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational psychiatry. vol 2. 2013-03-04. PMID:22832859. |
cannabidiol is a component of marijuana that does not activate cannabinoid receptors, but moderately inhibits the degradation of the endocannabinoid anandamide. |
2013-03-04 |
2023-08-12 |
Not clear |
| Franjo Grotenhermen, Kirsten Müller-Vah. The therapeutic potential of cannabis and cannabinoids. Deutsches Arzteblatt international. vol 109. issue 29-30. 2013-03-01. PMID:23008748. |
the therapeutic potential of cannabis and cannabinoids. |
2013-03-01 |
2023-08-12 |
Not clear |
| Tim Karl, Jonathon C Arnol. What does a mouse tell us about neuregulin 1-cannabis interactions? Frontiers in cellular neuroscience. vol 7. 2013-03-01. PMID:23447438. |
the studies suggest a complex interaction between cannabis and nrg1: the neuro-behavioral effects of cannabinoids were different in nrg1 mutant and control mice and depended on exposure time, sex, and age of test animals. |
2013-03-01 |
2023-08-12 |
mouse |
| Joseph P Schacht, Kent E Hutchison, Francesca M Filbe. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 37. issue 11. 2013-02-26. PMID:22669173. |
associations between cannabinoid receptor-1 (cnr1) variation and hippocampus and amygdala volumes in heavy cannabis users. |
2013-02-26 |
2023-08-12 |
Not clear |
| Priyamvada Sharma, Pratima Murthy, M M Srinivas Bharat. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iranian journal of psychiatry. vol 7. issue 4. 2013-02-15. PMID:23408483. |
although it is used as a recreational drug, it can potentially lead to dependence and behavioral disturbances and its heavy use may increase the risk for psychotic disorders.many studies that endeavor to understand the mechanism of action of cannabis concentrate on pharmacokinetics and pharmacodynamics of cannabinoids in humans. |
2013-02-15 |
2023-08-12 |
human |
| Caio Fabio Baeta Lopes, Bruno Brandão de Angelis, Henrique Maciel Prudente, Bernardo Vieira Goulart de Souza, Sérgio Vitorino Cardoso, Rosy Iara Maciel de Azambuja Ribeir. Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: recent advances and challenges. Archives of oral biology. vol 57. issue 8. 2013-02-14. PMID:22727410. |
carcinogens found in tobacco are also concentrated in marijuana, but the latter also contains high levels of cannabinoids, bioactive compounds responsible for several effects such as euphoria and analgesia. |
2013-02-14 |
2023-08-12 |
Not clear |
| Erin L Karschner, David M Schwope, Eugene W Schwilke, Robert S Goodwin, Deanna L Kelly, David A Gorelick, Marilyn A Huesti. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. Drug and alcohol dependence. vol 125. issue 3. 2013-02-12. PMID:22464363. |
predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (thc) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral thc. |
2013-02-12 |
2023-08-12 |
Not clear |
| Zana Bruci, Ioannis Papoutsis, Sotirios Athanaselis, Panagiota Nikolaou, Ermira Pazari, Chara Spiliopoulou, Gentian Vyshk. First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. Forensic science international. vol 222. issue 1-3. 2013-02-12. PMID:22608266. |
the aim of this study was to determine thc, cbd and cbn in a significant number of cannabis samples of albanian origin, where cannabis is the most frequently used drug of abuse, in order to evaluate and classify them according to their cannabinoid composition. |
2013-02-12 |
2023-08-12 |
Not clear |
| Zana Bruci, Ioannis Papoutsis, Sotirios Athanaselis, Panagiota Nikolaou, Ermira Pazari, Chara Spiliopoulou, Gentian Vyshk. First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. Forensic science international. vol 222. issue 1-3. 2013-02-12. PMID:22608266. |
the highest cannabinoid concentrations were found in the flowers of cannabis. |
2013-02-12 |
2023-08-12 |
Not clear |
| Zana Bruci, Ioannis Papoutsis, Sotirios Athanaselis, Panagiota Nikolaou, Ermira Pazari, Chara Spiliopoulou, Gentian Vyshk. First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. Forensic science international. vol 222. issue 1-3. 2013-02-12. PMID:22608266. |
the cannabinoid content of cannabis plants were used for their profiling, and it was used for their classification, according to their geographical origin. |
2013-02-12 |
2023-08-12 |
Not clear |
| Sebastian Rojek, Małgorzata Kłys, Marcin Strona, Martyna Maciów, Karol Kul. "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration. Forensic science international. vol 222. issue 1-3. 2013-02-12. PMID:22648055. |
the easily available "legal highs", which are products containing psychoactive substances, such as cathinones, piperazines and synthetic cannabinoids, are abused by adolescents in poland and in the world as alternatives to classic drugs, such as amphetamines or marijuana. |
2013-02-12 |
2023-08-12 |
Not clear |
| Shannon Thomas, Sarah Bliss, Mohammed Mali. Suicidal ideation and self-harm following K2 use. The Journal of the Oklahoma State Medical Association. vol 105. issue 11. 2013-02-12. PMID:23304900. |
there is emerging evidence of adverse effects associated with k2 and similar synthetic cannabinoid compounds marketed as herbal alternatives to marijuana. |
2013-02-12 |
2023-08-12 |
Not clear |
| Karl B Scheidweiler, Nathalie A Desrosiers, Marilyn A Huesti. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clinica chimica acta; international journal of clinical chemistry. vol 413. issue 23-24. 2013-02-01. PMID:22771478. |
we are conducting a controlled drug administration study investigating efficacy of urinary cannabinoid glucuronide metabolites for documenting recency of cannabis intake and for determining stability of urinary cannabinoids. |
2013-02-01 |
2023-08-12 |
human |
| John Charles A Lacson, Joshua D Carroll, Ellenie Tuazon, Esteban J Castelao, Leslie Bernstein, Victoria K Cortessi. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. vol 118. issue 21. 2013-01-31. PMID:22965656. |
germ cell function may be influenced by cannabinoids, and 2 prior epidemiologic studies reported that the use of marijuana may be associated with nonseminomatous tgct. |
2013-01-31 |
2023-08-12 |
Not clear |
| M B Forrester, K Kleinschmidt, E Schwarz, A Youn. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & experimental toxicology. vol 31. issue 10. 2013-01-29. PMID:22859662. |
synthetic cannabinoid and marijuana exposures reported to poison centers. |
2013-01-29 |
2023-08-12 |
Not clear |
| M B Forrester, K Kleinschmidt, E Schwarz, A Youn. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & experimental toxicology. vol 31. issue 10. 2013-01-29. PMID:22859662. |
this investigation compared synthetic cannabinoids and marijuana exposures reported to a large statewide poison center system. |
2013-01-29 |
2023-08-12 |
Not clear |
| M B Forrester, K Kleinschmidt, E Schwarz, A Youn. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & experimental toxicology. vol 31. issue 10. 2013-01-29. PMID:22859662. |
synthetic cannabinoid and marijuana exposures reported to texas poison centers during 2010 were identified. |
2013-01-29 |
2023-08-12 |
Not clear |
| M B Forrester, K Kleinschmidt, E Schwarz, A Youn. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & experimental toxicology. vol 31. issue 10. 2013-01-29. PMID:22859662. |
the distribution of exposures to the two agents with respect to various demographic and clinical factors were compared by calculating the rate ratio (rr) of the synthetic cannabinoid and marijuana percentages for each subgroup and 95% confidence interval (ci). |
2013-01-29 |
2023-08-12 |
Not clear |
| M B Forrester, K Kleinschmidt, E Schwarz, A Youn. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & experimental toxicology. vol 31. issue 10. 2013-01-29. PMID:22859662. |
the proportion of synthetic cannabinoid and marijuana exposures, respectively, were 87.3% and 46.5% via inhalation (rr 1.88, 95% ci 1.38-2.61), 74.9% and 65.7% in male (rr 1.14, 95% ci 0.87-1.51), 40.2% and 56.6% age ≤ 19 years (rr 0.71, 95% ci 0.52-0.98), 79.2% and 58.6% occurring at a residence (rr 1.35, 95% ci 1.02-1.82), 8.4% and 16.2% managed on-site (rr 0.52. |
2013-01-29 |
2023-08-12 |
Not clear |